Pilot Study Evaluating Maraviroc (Celsentri)Intensification Benefit in HIV Infected Patients Presenting Insufficient Immune Restoration Despite Controlled Viral Load With Antiretroviral Treatment. ANRS 145 MARIMUNO.

Trial Profile

Pilot Study Evaluating Maraviroc (Celsentri)Intensification Benefit in HIV Infected Patients Presenting Insufficient Immune Restoration Despite Controlled Viral Load With Antiretroviral Treatment. ANRS 145 MARIMUNO.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Feb 2016

At a glance

  • Drugs Maraviroc (Primary)
  • Indications HIV-1 infections
  • Focus Biomarker; Therapeutic Use
  • Acronyms MARIMUNO
  • Most Recent Events

    • 25 Feb 2016 Results (n=22) presented at the 23rd Conference on Retroviruses and Opportunistic Infections
    • 10 Feb 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 10 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top